Database » Life Sciences Companies » Therapeutics » AVA


Sector: Biotechnology - Therapeutics
Medical Field: Veterinary
Technological Field: Genetic resistance to viruses
Year Established: 2007
Stage: Seed

AVA is developing special molecules that will be planted into cells. The company's technology will cause a borne animal to be resistant to different viruses AVA defines. The company focuses on a technology to turn poultry to be resistant to the avian influenza virus. This AVA will create a barrier and block the deadly disease in poultry that will not pass it to human.

Contact Info

Contact Person Lior Zigler, CEO & Founder
Address 2 Hillel St., Jerusalem 94581, Israel
Phone 972-2-6235987
Cellular 972-52-2675071
Fax 972-2-6258016